Vancouver, British Columbia--(Newsfile Corp. - March 14, 2019) - Vanity Capital Inc. (TSXV: VYC) (the "Company") and XynaRx Pharmaceuticals Corp. ("XynaRx") are pleased to announce the entering into of an arm's length binding letter of intent (the "LOI") accepted effective March 11, 2019, pursuant to which the Company will acquire all of the issued and outstanding shares in the capital of XynaRx. The previously announced non-binding letter of intent between the Company and Akseera Pharma Corp. was terminated by agreement between the parties.It is currently anticipated that the Transaction will...
Vancouver, British Columbia--(Newsfile Corp. - November 28, 2018) - Vanity Capital Inc. (TSXV: VYC) (the "Company") is pleased to announce that it has entered into a binding letter of intent dated Nov. 27, 2018, (the "Letter of Intent") with Akseera Pharma Corp., a private Canadian corporation ("Akseera"), in connection with a proposed reverse take-over of the Company (the "Proposed Transaction") subject to approval of the TSX Venture Exchange (the "Exchange") to list the shares of the resulting entity (the "Resulting Issuer") on the Exchange. The Resulting Issuer will operate as a life scienc...
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.